Communications Biology (Mar 2022)
OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR
Abstract
OTUD6A, a deubiquitinase, is amplified in prostate cancer and correlates with poor survivability, increasing the growth of prostate cancer cell lines and PDX models. OTUD6A stabilizes the expression of Brg1 and AR through the removal of K27- and K11-linked polyubiquination.